authors
-
Piotr Radziszewski, Andrzej Borkowski
- Katedra i Klinika Urologii AM w Warszawie
Kierownik Kliniki: prof. dr hab. n. med. A. Borkowski
keywords
-
urinary tract urine-voiding disorders treatment
references
- [1] Abrams, R, Schulman, C. C, Vaage, S. i wsp.: Tamsulosin, a selective
- ?lc-adrenoceptor antagonist, a randomized, controlled trial in patients with
- benign prostatic ?obstruction" (Symptomatic BPH). Br. J. Urol. 1995, 76,
- 325-336.
- [2] Andersson, K. E.: Current concepts in treatment of disorders of micturition.
- Drugs 1988, 35, 477-494.
- [3] Andersson, K. E.: Pharmacology of lower urinary tract smooth muscles and
- penile tissues. Pharm. Reviews 1993, 45, 253-307.
- [4] Andersson, K. E., Fovaeus, M., Morgan, E. i wsp.: Comparative effects of
- five different calcium channel blockers on the atropine resistant contractions
- in electrically stimulated rabbit urinary bladder. Neurol. Urodyn. 1986, 5,
- 579-586.
- [5] Awad, S., Downie, ]., Kiruluta, H.: Alpha adrenergic agents in urinary di-
- sorders of the proximal urethra. I. Stress incontinence. Br. J. Urol. 1978, 50,
- 332-335.
- [6] Awad, S. A.: Clinical use of betanechol. J. Urol. 1985, 134, 523-524.
- [7] Baggioni, I., Omot, J., Stewart, C. K.: The potent pressor effect ofphenylpro-
- panolamine in patients with autonomie impairment. J. Am. Med. Assoc. 1987,
- 258, 236-239.
- [8] Baltitude, M., Hills, N., Shuttelworth, K.: Clinical and experimental stu-
- dies on the action of Prostaglandins and their synthesis inhibitors on detrusor
- muscle in vitro and in vivo. Br. J. Urol. 1976, 48, 631-637.
- [9] Batra, S. C, Josif, S. C: Female urethra: a target for estrogen action. J. Urol.
- 1983, 129, 418-420.
- [10] Bergman, A, Stanczyk, F. Z., Lobio, R. A.: The role of Prostaglandins in de-
- trusor instability. Am. J. Obstet. Gynecol. 1991, 165, 1833-1836.
- [11] Briggs, R. S., Castleden, C. M., Asher, M. J.: The effect offlavoxate on unin-
- hibitun. in. hibit. ed detrusor contractions and urinary continence in the eldery.
- J. Urol. 1980, 123, 656-666.
- [12] Buzelin, J. M., Geffriaud-Ricouard, C, Delauche-Cavalier, M. C. i wsp.:
- A double blind, placebo-controlled trial of the efficacy and safety of sustained
- release alfuzosin in Symptomatic benign prostatie hyperplasia (BPH). J. Urol.
- 1995, 153 Suppl., 274A.
- [13] Castelden, C. M., George, C. E, Renwick, A. G. i wsp.: Imipraminę ?
- a possible alternative to current therapy for urinary incontinence in the eldery.
- J. Urol. 1981, 125, 218-320.
- [14] Christensen, M. M, Holme, J. B., Rasmussen, P. C. i wsp.: Doxazosin tre-
- atment in patients with prostatic obstruction. Scand. J. Urol. Nephrol. 1993,
- 27, 39-44.
- [15] Czernecki, J.: Indeks leków 1997. Środki medyczne i materiały farmaceutycz-
- ne zarejestrowane w Polsce. JWC Warszawa 1997.
- [16] Davidoff, R. A.: Antispasticity drugs: mechanism of action. Ann. Neurol. 1975,
- 17, 107-116.
- [17] Diokno, A. C, Lapides, J.: Action of oral and parenteral betanechol on decom-
- pensated bladder. Urology 1977, 10, 23-24.
- [18] Ek, A., Andersson, K. E., Gullberg, B. i wsp.: The effects of long-term treat-
- ment with norphedrin on stress incontinence and urethral dossure pressure pro.
- file. Scand. J. Urol. Nephrol. 1978, 12, 105-110.
- [19] Ekland, A., Sander, S.: Urodynamic study of emperonium bromide in bladder
- dysfunction. Scand. J. Urol. Nephrol. 1976, 10, 195199.
- [20] Elbadawi, A.: Functional anatomy of the organs of micturition. Urol. Clin.
- North America 1996, 23 (2), 177-210.
- [21] Elliott, R. A., Norman, R. I., Parker, S. G. i wsp.: Effect of treatment with
- calcium antagonists in vitro and in vivo on the contractile response of isolated
- rat and human detrusor muscle. Clin. Sci. 1996, 91 (4), 467474.
- [22] Fisher, C, Dioko, A., Lapides, J.: The anticholinergic effects of dicyclomine
- hydrochloride in uninhibited bladder dysfunction. J. Urol. 1978, 120, 328-329.
- [23] Florante, }., Leyson, }., Martin, B. i wsp.: Baclofen in the treatment of de-
- trussor-sphincter dyssynergy in spinal cord injury patients. J. Urol. 1980, 124,
- 82-84.
- [24] Gruneberg, A.: Treatment of motor urge incontinence with clerbuterol and fla-
- voxate hydrochloride. B. J. Obstet. Gyn. 1984, 91, 275-278.
- [25] Hackler, R., Broecker, B., Klein, R i wsp.: A clinical experience with dantro-
- lene sodium for external urinary sphincter hypertonicity in spinal cord injured
- patients. J. Urol. 1981, 124, 78-81.
- [26] Kiesswetter, H., Schober, W.: Lioresal in the tratment of neurogenic bladder
- dysfunction. Urol. Int. 1975, 30, 63-71.
- [27] Krane, L., Olsson, C: Phenoxybenmtzine in neurogenic bladder dysfunction.
- I. Clinical considerations. J. Urol. 1973a, 110, 650-653.
- [28] Maggi, C. A.: Capsaicin and primary afferent neurons: from basic Science to
- human therapy. J. Auton. Neuro. Syst. 1991, 33, 1-14.
- [29] McCallum, R., Albibi, R.: Metoclopramide: pharmacology and clinical appli-
- cation. Ann. Intern. Med. 1983, 98, 86-95.
- [30] Mitchel, W. C, Venable, D. D.: Effects of metoclopramide on detrusor func-
- tion. }. Urol. 1985, 134, 791-794.
- [31] Muskat, Y. , Bukovsky, I. , Schneider, D. i wsp.: The use of scopolamine in
- the treatment of detrusor instability. J. Urol. 1996, 156, 1989-1990.
- [32] Nitti, V. W.: Intravesical capsaicin for treatment of the neurogenic bladder.
- Lancet 1994, 343, 1448.
- [33] Obrink, A., Bunne, G.: The effect of alpha adrenergic stimulation in stress in-
- continence. Scand. J. Urol. Nephrol. 1978, 12, 205-208.
- [34] Podlewski, J. K., Chwalibogowska-Podlewska, A.: Leki zuspółczesnej tera-
- pii. Split Trading, Warszawa 1994.
- [35] Riccabona, M.: Conservative treatment of urine-voiding disorders due to
- a hypocontractile bladder. Dtch. Med. Wschr. 1981, 106, 1579-1582.
- [36] Rondot, P., Marchand, M. P., Dellatolas, G.: Spasmodic torticollis - re-
- view of 220 patients. Can. J. Neurol. Sci. 1991, 18, 143-151.
- [37] Schreiter, R, Fuchs, R, Stockamp, K.: Estrogenie sensitivity of alpha recep-
- tors in the urethral musculature. Urol. Int . 1976, 31, 13-19.
- [38] Shah, P. J. R., Abrams, R, Choa, R. G.: Distigmine bromide and postprosta-
- tectomy voiding. Br. J. Urol. 1983, 55, 229-232.
- [39] Szollar, S. M., Lee, S. M.: Intravesical oxybutynin for spinal cord injury pa-
- tients. Spinal Cord 1996, 34, 284-287.
- [40] Wein, A. J.: Classification of neurogenic voiding dysfunction. J. Urol. 1981,
- 125, 605-609.
|